| Range: | 1.75-3.4 | Vol Avg: | 23239 | Last Div: | 0 | Changes: | 0.02 |
| Beta: | 0.77 | Cap: | 0.16B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Mon Mar 08 2021 | Empoloyees: | 121 | ||
| CUSIP: | M0740A108 | CIK: | 0001871321 | ISIN: | IL0011839383 | Country: | IL |
| CEO: | Mr. Uzi Sofer | Website: | https://www.alphatau.com | ||||
DRTS 2.50 Stock Price Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow